NCT05295992 2026-03-06
ARTIA-Vesica
Varian, a Siemens Healthineers Company
Phase NA Active not recruiting
Clinical Trials
11 trialsNCT04506554 2025-07-04
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer
Fox Chase Cancer Center
Phase 2 Active not recruiting
NCT05028660 2025-05-09
AUR93A
Elypta
Completed
NCT04724928 2025-01-15
EFFORT-MIBC
University Hospital, Ghent
Phase 2 Recruiting
NCT05203913 2024-10-04
CNN-BC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Recruiting
NCT06325423 2024-03-26
Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Assiut University
Not yet recruiting
NCT05767528 2023-03-14
Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection
Chinese PLA General Hospital
Unknown
NCT05221827 2023-02-27
Clinical Performance Evaluation of the C2i-Test
C2i Genomics
Terminated
NCT04876313 2022-04-06
NURE-Combo
IRCCS San Raffaele
Phase 2 Unknown
NCT04966130 2021-07-19
Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT04909775 2021-06-02
Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer
Ruijin Hospital
Phase 2 Unknown